A detailed history of Rise Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Rise Advisors, LLC holds 39 shares of EMBC stock, worth $478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Holding current value
$478
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$9.28 - $13.3 $361 - $518
39 New
39 $0
Q2 2022

Jul 28, 2022

BUY
$24.78 - $33.36 $74 - $100
3 New
3 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $710M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.